Skip Navigation


Europace Advance Access originally published online on May 10, 2006
Europace 2006 8(6):416-420; doi:10.1093/europace/eul033
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
8/6/416    most recent
eul033v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kihel, J.
Right arrow Articles by Isaaz, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kihel, J.
Right arrow Articles by Isaaz, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


AVNRT

Long-term efficacy and safety of radiofrequency ablation in elderly patients with atrioventricular nodal re-entrant tachycardia

Jalila Kihel1, Antoine Da Costa1,*, Abdel Kihel1, Cécile Roméyer-Bouchard1, Jérôme Thévenin1, Régis Gonthier2, Bernard Samuel1 and Karl Isaaz1

1 Division of Cardiology, University Jean Monnet of Saint-Etienne (JK, A, DC, AK, CRB, JT, BS, KI); 2 Department of Medicine for the Elderly, University Jean Monnet of Saint-Etienne (RG), 42000 Saint-Etienne, France

Aims The purpose of this study was to evaluate the efficacy, risks, safety, and follow-up of radiofrequency (RF) catheter ablation of atrioventricular nodal re-entrant tachycardia (AVRNT) in patients (pts) ≥75 years old (n=42) (GpI) compared with pts younger than 75 years (n=234) (GpII).

Methods and results The study population consisted of 276 consecutive pts (39.5% men/60.5% women), from 15 to 98-year-old (average 56±17 years) with AVRNT referred for RF ablation (RFA) from October 1997 to January 2004. Combined anatomical and electrogram approaches were used to guide RFA. The cumulative risk of AVRNT recurrence was analysed by the Kaplan–Meier method and log-rank test. The average follow-up was 34±18 months. GpI (80±4 years) differed significantly from GpII (51±14 years) regarding: heart rate tachycardia (160±20 vs. 180±30 bpm; P=0.0001), the slow pathway antegrade refractory period (370±70 vs. 340±60 ms; P=0.01), the fast pathway antegrade refractory period (360±60 vs. 330±60 ms; P=0.003), retrograde refractory period (360±60 vs. 330±60 ms; P=0.0007), left ventricular ejection fraction (60±12 vs. 65±7%; P=0.0009), and ischaemic ECG signs during tachycardia (76.2% vs. 61%; P=0.09). RFA was successfully obtained in 275/276 (99.6%), 42/42 in GpI (100%), and 233/234 (99.6%) in GpII. Five complications occurred (1.8%): major complications in two pts (0.7%) and minor complications in three pts (1.1%). Major complications were deep venous thrombosis with pulmonary embolus (n=1) and pericardial effusion (n=1), minor complications were groin haematoma (n=3). One complication was observed in GpI (groin haematoma) (2.4%) and four in GpII (deep venous thrombosis with pulmonary embolus in one, groin haematoma in two, and pericardial effusion in one) (1.7%). The number of recurrences was not statistically different between the two groups (0 vs. 3.4%; P=0.5) with a respective average follow-up of 28±18 and 35±18 months, respectively.

Conclusion Catheter ablation of AVRNT in elderly and very elderly pts appears to be a reasonable approach regarding feasibility and effectiveness without increasing the risk of AV block.

Key Words: AVRNT, Elderly, Catheter ablation, Geriatrics


* Corresponding author: Service de Cardiologie, Hôpital Nord, Centre Hospitalier Universitaire de Saint-Etienne, 42 055 Saint-Etienne Cedex 2, France. Tel: +33 4 77 82 83 40; fax: +33 4 77 82 84 51. E-mail address: dakosta{at}aol.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
B. A. Schaer, A. Maurer, C. Sticherling, P. T. Buser, and S. Osswald
Routine echocardiography after radiofrequency ablation: to flog a dead horse?
Europace, February 1, 2009; 11(2): 155 - 157.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace, May 1, 2008; 10(5): 513 - 527.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.